ATE493133T1 - Antibiotische/analgetische formulierung und verfahren zur herstellung dieser formulierung - Google Patents

Antibiotische/analgetische formulierung und verfahren zur herstellung dieser formulierung

Info

Publication number
ATE493133T1
ATE493133T1 AT01997308T AT01997308T ATE493133T1 AT E493133 T1 ATE493133 T1 AT E493133T1 AT 01997308 T AT01997308 T AT 01997308T AT 01997308 T AT01997308 T AT 01997308T AT E493133 T1 ATE493133 T1 AT E493133T1
Authority
AT
Austria
Prior art keywords
formulation
antibiotic
analgesic
producing
solvent
Prior art date
Application number
AT01997308T
Other languages
English (en)
Inventor
Richard Mihalik
Original Assignee
Teva Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Animal Health Inc filed Critical Teva Animal Health Inc
Application granted granted Critical
Publication of ATE493133T1 publication Critical patent/ATE493133T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01997308T 2000-11-27 2001-11-27 Antibiotische/analgetische formulierung und verfahren zur herstellung dieser formulierung ATE493133T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/723,064 US6787568B1 (en) 2000-11-27 2000-11-27 Antibiotic/analgesic formulation and a method of making this formulation
PCT/US2001/044315 WO2002041899A1 (en) 2000-11-27 2001-11-27 An antibiotic/analgesic formulation and a method of making this formulation

Publications (1)

Publication Number Publication Date
ATE493133T1 true ATE493133T1 (de) 2011-01-15

Family

ID=24904677

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01997308T ATE493133T1 (de) 2000-11-27 2001-11-27 Antibiotische/analgetische formulierung und verfahren zur herstellung dieser formulierung

Country Status (9)

Country Link
US (1) US6787568B1 (de)
EP (2) EP2351570A1 (de)
AT (1) ATE493133T1 (de)
AU (2) AU2002217891B2 (de)
CA (1) CA2430091C (de)
DE (1) DE60143765D1 (de)
DK (1) DK1345611T3 (de)
ES (1) ES2356602T3 (de)
WO (1) WO2002041899A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
EP1875913A1 (de) * 2002-05-20 2008-01-09 Schering-Plough Ltd. Zusammensetzungen und Verfahren zur Behandlung von Infektionen von Rindern und Schweinen
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
ES2201908B1 (es) * 2002-05-29 2005-02-16 Laboratorios Del Dr. Esteve, S.A. Pienso suplementado con ketoprofeno y su empleo en el tratamiento de procesos que cursan con fiebre, inflamacion y/o dolor, en un colectivo de animales, de forma simultanea.
ATE402923T1 (de) * 2002-09-17 2008-08-15 Hoffmann La Roche 2,4-substituierte indole und deren verwendung als 5-ht6 modulatoren
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US6918561B2 (en) * 2002-10-31 2005-07-19 Yon So Chong Shell assembly for winding tire cord strip or belt cord strip
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
PE20050386A1 (es) 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
PT1502589E (pt) * 2003-07-31 2006-10-31 Emdoka Bvba Drug Registration Suspensoes injectataveis aquosas veterinarias contendo florfenicol
CA2542509A1 (en) * 2003-10-29 2005-05-19 Idexx Laboratories, Inc. Salts of pharmacologically active compounds
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
WO2006120494A1 (fr) * 2005-05-13 2006-11-16 Advanced Scientific Developements Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l’eugenol, le borneol et les carvacrol
KR100748251B1 (ko) * 2006-05-08 2007-08-10 주식회사 삼양애니팜 플로르페니콜 함유 주사용 조성물
CA2672795A1 (en) 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US7550625B2 (en) 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
WO2009143558A1 (en) * 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
JP2011529895A (ja) 2008-07-30 2011-12-15 インターベツト・インターナシヨナル・ベー・ベー フロルフェニコール中間体として有用なオキサゾリン保護アミノジオール化合物を調製する方法
CN101912405A (zh) * 2010-08-11 2010-12-15 吉林大学 一种治疗牛子宫内膜炎的药物组合物
CN102188422B (zh) * 2011-01-11 2013-11-06 广东大华农动物保健品股份有限公司 一种复方氟苯尼考注射液及其制备方法和应用
AU2015268626C1 (en) * 2011-01-20 2019-11-28 Elanco New Zealand Injectable compositions for mastitis comprising an NSAID and an antibiotic in a non-aqueous solvent
NZ588686A (en) * 2011-01-20 2013-07-26 Bayer New Zealand Ltd Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland
RU2623084C2 (ru) * 2015-06-23 2017-06-21 Федеральное государственное бюджетное учреждение науки Институт биологии Коми научного центра Уральского отделения Российской академии наук Способ одновременного получения гиперицина и псевдогиперицина
IL271777B1 (en) 2017-07-07 2024-05-01 Epicentrx Inc Preparations for intravenous administration of medical substances
CN107260664A (zh) * 2017-07-28 2017-10-20 吉林省力畜达动物药业有限公司 一种复方氟尼辛葡甲胺注射液及其制备方法
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
CN108619142B (zh) * 2018-06-22 2019-09-24 山东鲁抗舍里乐药业有限公司 一种长效复方氟苯尼考注射液及其制备方法
CN109602701A (zh) * 2019-02-22 2019-04-12 湖北九州通中加医药有限公司 一种地塞米松磷酸钠注射液及其制备方法
CN114404360B (zh) * 2021-12-16 2023-03-28 江西益昕葆生物科技有限公司 一种氟尼辛葡甲胺注射液的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE6466T1 (de) * 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
FR2648348B2 (fr) * 1988-12-02 1991-10-04 Grimberg Georges Creme dermatologique auto-emulsionnable
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5723495A (en) * 1995-11-16 1998-03-03 The University Of North Carolina At Chapel Hill Benzamidoxime prodrugs as antipneumocystic agents
AU731799B2 (en) * 1997-05-06 2001-04-05 Norbrook Laboratories Limited Improvements in or relating to long-acting antimicrobials
IT1295369B1 (it) * 1997-10-21 1999-05-12 Fatro Spa Composizione a base di tiamfenicolo e diclofenac
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine

Also Published As

Publication number Publication date
CA2430091A1 (en) 2002-05-30
DK1345611T3 (da) 2011-03-14
EP2351570A1 (de) 2011-08-03
EP1345611B1 (de) 2010-12-29
EP1345611A1 (de) 2003-09-24
ES2356602T3 (es) 2011-04-11
US6787568B1 (en) 2004-09-07
EP1345611A4 (de) 2005-11-16
CA2430091C (en) 2010-08-03
AU2002217891B2 (en) 2005-12-22
DE60143765D1 (de) 2011-02-10
WO2002041899A1 (en) 2002-05-30
AU1789102A (en) 2002-06-03

Similar Documents

Publication Publication Date Title
ATE493133T1 (de) Antibiotische/analgetische formulierung und verfahren zur herstellung dieser formulierung
ATE239452T1 (de) Verfahren zur herstellung fester pharmazeutischer formen durch extrudierung
ECSP034430A (es) Esteres oxigenados de acidos 4-yodo fenilamino benzhidroxamcios
MX9203653A (es) Composiciones amfotericas y formas polimericas de los alfa-hidroxiacidos.
ES2188005T3 (es) Derivados de amidas para el tratamiento de enfermedades mediadas por citoquinas.
GB2326093A (en) Avermectin formulation
DK1284716T3 (da) Selvemulgerende aktivstofformulering og anvendelse af denne formulering
DE69218762T2 (de) Therapeutische zusammensetzungen zum schutz und zur wiederbelebung von säugetierzellen und verfahren zu deren herstellung und anwendung
ATE287707T1 (de) Injizierbare propofol-formulierungen
ECSP045209A (es) Nuevos esteres de ácidos fluoreno - carboxilicos, procedimientos para su preparación asi como su utilización en calidad de medicamentos
DE69809074T2 (de) Herstellung von arzneimitteln
GT199600098A (es) Formulaciones de quinolona inyectables.
CY1108401T1 (el) Παραγωγα πυρρολοϊμιδαζολης, η παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιεχουν και η χρηση τους ως νοοτροπικων παραγοντων
DE50000866D1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
DE602004017705D1 (de) Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür
DE602004019777D1 (de) STABILE PHARMAZEUTISCHE ZUBEREITUNGEN MIT 2-AZA-BICYCLOi3.3.0 -OCTAN-3-CARBOXYLSÄURE-DERIVATEN
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
ATE338047T1 (de) Stickstoffbasierte camptothecin-derivate
DE69924846D1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
ATE326955T1 (de) Verfahren zur kontinuierlichen herstellung und beschichtung von selbstklebemassen auf basis von sbc mit mindestens einem pharmazeutischen wirkstoff
ES2084328T3 (es) Mezcla de estabilizador.
DE68917937T2 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DE69904585D1 (de) Verfahren zur Herstellung von Mometason Furoat
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
ATE298567T1 (de) Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties